Blog
The Power of LinkedIn for Life Science Professionals – Diana Caldwell to deliver presentation at Purdue Foundry
Join Diana Caldwell, President and CEO of Pearl IRB, this Friday, December 1, 2017 at Purdue Foundry as she discusses "The Power of LinkedIn for Life Science Professionals." Foundry Grounds occurs each Friday and involves conversations, presentations &...
Don’t wine about FDA – Gretchen Bowker will lead regulatory approval discussion with VisionTech
Gretchen Bowker, COO and Head of Quality at Pearl IRB, will discuss the regulatory approval process at the VisionTech Partners meeting on Thursday, November 30, 2017. The event, "Don't Wine about FDA - Regulatory 101 with Pearl Pathways," is open to...
Clinical trial data sources bound to increase and diversify
It should come as no surprise that the volume and diversity of clinical trial data is expected to rapidly increase over the next few years. The proliferation of mobile health tech, real world evidence (RWE), electronic data capture (EDC) systems, etc. in...
FDA issues draft guidance that would clarify and extend ICH E9 guideline on clinical trial analyses
The U.S. Food and Drug Administration (FDA) issued a draft guidance suggesting the agency adopt an International Council for Harmonization (ICH) to a 1998 clinical trials statistics guideline. The original ICH guideline (ICH E9) focused on the use of...
Pearl IRB will sponsor IMDMC 2017 Annual Conference
Pearl IRB is excited to attend and sponsor the IMDMC Annual Conference tomorrow, November 1, 2017 at the Montague Banquet Center in Indianapolis. This conference provides an opportunity for networking, collaboration, and discussion of recent news and...